31 related articles for article (PubMed ID: 36544038)
1. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract][Full Text] [Related]
2. The expression and clinical significance of signal transducer and activator of transcription 3, tumor necrosis factor α induced protein 8-like 2, and runt-related transcription factor 1 in breast cancer patients.
Lan D; Jin X; Li M; He L
Gland Surg; 2021 Mar; 10(3):1125-1134. PubMed ID: 33842256
[TBL] [Abstract][Full Text] [Related]
3. RUNX1-Regulated Signaling Pathways in Ovarian Cancer.
Chen Y; He Y; Liu S
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760803
[TBL] [Abstract][Full Text] [Related]
4. Germline and somatic RUNX1 variants in a pediatric bone marrow failure cohort.
Yamamori A; Hamada M; Muramatsu H; Wakamatsu M; Hama A; Narita A; Tsumura Y; Yoshida T; Doi T; Terada K; Higa T; Yamamoto N; Miura H; Shiota M; Watanabe K; Yoshida N; Maemura R; Imaya M; Miwata S; Narita K; Kataoka S; Taniguchi R; Suzuki K; Kawashima N; Nishio N; Iwafuchi H; Ito M; Kojima S; Okuno Y; Takahashi Y
Am J Hematol; 2023 May; 98(5):E102-E105. PubMed ID: 36740830
[No Abstract] [Full Text] [Related]
5. RUNX1 Upregulation Causes Mitochondrial Dysfunction via Regulating the PI3K-Akt Pathway in iPSC from Patients with Down Syndrome.
Liu Y; Zhang Y; Ren Z; Zeng F; Yan J
Mol Cells; 2023 Apr; 46(4):219-230. PubMed ID: 36625318
[TBL] [Abstract][Full Text] [Related]
6. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
[TBL] [Abstract][Full Text] [Related]
7. RUNX transcription factors are essential in maintaining epididymal epithelial differentiation.
Toriseva M; Björkgren I; Junnila A; Mehmood A; Mattsson J; Raimoranta I; Kim B; Laiho A; Nees M; Elo L; Poutanen M; Breton S; Sipilä P
Cell Mol Life Sci; 2024 Apr; 81(1):183. PubMed ID: 38630262
[TBL] [Abstract][Full Text] [Related]
8. RUNX transcription factors: biological functions and implications in cancer.
Chen X; Wang L; Yang M; Zhao W; Tu J; Liu B; Yuan X
Clin Exp Med; 2024 Mar; 24(1):50. PubMed ID: 38430423
[TBL] [Abstract][Full Text] [Related]
9. Runx1 Deficiency Promotes M2 Macrophage Polarization Through Enhancing STAT6 Phosphorylation.
Zhou S; Zhao T; Chen X; Zhang W; Zou X; Yang Y; Wang Q; Zhang P; Zhou T; Feng T
Inflammation; 2023 Dec; 46(6):2241-2253. PubMed ID: 37530929
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.
Chuang KT; Chiou SS; Hsu SH
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444447
[TBL] [Abstract][Full Text] [Related]
11. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
[TBL] [Abstract][Full Text] [Related]
12. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1.
Zhu SY; Wu QY; Zhang CX; Wang Q; Ling J; Huang XT; Sun X; Yuan M; Wu D; Yin HF
Biochem Biophys Res Commun; 2018 Oct; 505(1):309-316. PubMed ID: 30249397
[TBL] [Abstract][Full Text] [Related]
13. The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.
Riggio AI; Blyth K
FEBS J; 2017 Aug; 284(15):2345-2362. PubMed ID: 28304148
[TBL] [Abstract][Full Text] [Related]
14. RUNX1-dependent mechanisms in biological control and dysregulation in cancer.
Hong D; Fritz AJ; Gordon JA; Tye CE; Boyd JR; Tracy KM; Frietze SE; Carr FE; Nickerson JA; Van Wijnen AJ; Imbalzano AN; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2019 Jun; 234(6):8597-8609. PubMed ID: 30515788
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer.
Zheng LL; Cai L; Zhang XQ; Lei Z; Yi CS; Liu XD; Yang JG
Curr Med Sci; 2022 Dec; 42(6):1285-1296. PubMed ID: 36544038
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
